← Back to Search

Non-Invasive Respiratory Monitoring for Cerebral Palsy

N/A
Recruiting
Led By Tariq Rahman, PhD
Research Sponsored by Nemours Children's Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Subjects should have cerebral palsy a GMFCS levels IV, V
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve breathing in those with cerebral palsy, using a non-invasive sensor to detect respiratory distress and investigate the link with scoliosis.

Who is the study for?
This trial is for children with severe cerebral palsy, specifically those who are classified at GMFCS levels IV or V, indicating they have significant physical limitations. The study aims to help detect respiratory issues and understand the link between lung function and scoliosis in these patients.
What is being tested?
The trial is testing a new non-invasive respiratory sensor called pneuRIP. It's designed as a screening tool to identify breathing difficulties in kids with cerebral palsy and to explore how their lung health relates to spine curvature caused by scoliosis.
What are the potential side effects?
Since pneuRIP is a non-invasive sensor used for monitoring purposes, there are no direct side effects associated with its use. However, participation may involve some discomfort due to wearing the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Presence of pulmonary dysfunction

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: cerebral palsy groupExperimental Treatment1 Intervention
Respiratory sensor will measure breathing in patients with Cerebral palsy

Find a Location

Who is running the clinical trial?

Nemours Children's ClinicLead Sponsor
127 Previous Clinical Trials
18,133 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,840 Previous Clinical Trials
8,172,370 Total Patients Enrolled
7 Trials studying Cerebral Palsy
815 Patients Enrolled for Cerebral Palsy
Tariq Rahman, PhDPrincipal InvestigatorPrincipal Research Engineer
~110 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top